Skip to content

Moderna MRNA EV / EBITDA

EV / EBITDA at other companies

Pfizer logo
PfizerPFE
12.9×
ALN
Alnylam PharmaceuticalsALNY
52.6×
Roivant Sciences logo
Roivant SciencesROIV
1.8×
Biogen logo
BiogenBIIB
11.2×+2.8×
Merck & Co. logo
Merck & Co.MRK
23.1×+11.7×
Johnson & Johnson logo
Johnson & JohnsonJNJ
18.8×+4.2×

Other financials

Income statement

See full
Revenue$389.0M+260%
Gross profit-$566.0M-3,244%
Operating income-$1.4B-32.2%
Net income-$1.3B-38.3%
EPS (diluted)-$3.40-34.9%

Balance sheet

See full
Cash & equivalents$1.9B+17.4%
Total debt$1.3B+71.9%
Total equity$7.4B-26.4%
Total assets$11.5B-9.6%

Cash flow

See full
Operating cash flow-$630.0M+39.3%
CapEx$62.0M-47.0%
Free cash flow-$692.0M+40.0%

Valuation

See full
Market cap$25.38B+83.8%
Enterprise value$24.8B+93.6%
P/S11.4×+7.1×

Profitability

See full
Gross margin22.1%-32.0pp
Operating margin-153.3%+67.8pp
Net margin-143.6%+80.2pp

Returns & leverage

See full
Return on equity-36.6%+11.9pp
Debt / equity0.2×+0.1×
Current ratio2.4×-1.8×

Where this comes from

Calculated from Moderna’s reported figures.

Based on the most recent quarter.

The official record: Moderna’s 10-Q, filed August 1, 2024, on SEC EDGAR. View the filing →

Ask your AI about Moderna's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Moderna's EV / EBITDA?
Moderna (MRNA) reported EV / EBITDA of 50.1× in Q2 2023.
How has Moderna's EV / EBITDA changed year-over-year?
Moderna's EV / EBITDA increased by 1352.7% year-over-year, from 3.4× to 50.1×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.